It Lives

My colleague Mike Rosenwald has an intriguing piece today about a biotech company called Emergent BioSolutions and its controversial former arch-rival VaxGen. "The effort to protect the country from another anthrax attack will take an unexpected turn today when Rockville firm Emergent BioSolutions plans to announce that it has bought...

By Robert O'Harrow | May 6, 2008; 07:00 AM ET | Comments (2)